
Lifeist Wellness Inc. (TSXV:LFST) (FRANKFURT: M5B) (OTC:NXTTF) announced several business updates regarding its wholly owned U.S. subsidiary, Mikra, Cellular Sciences Inc., including the commencement of presales in the U.S. for its novel cellular therapeutic compound, CELLF, targeted at combating oxidative stress.
Meni Morim, the company’s CEO, called the launch of presale activities for CELLF a “meaningful momentum.”